面向营养物质输送器的纳米抑制剂对抗细胞内代谢重编程,用于对抗RT的HCC治疗
Yuehua Wang1,2, Zhenjie Wang3, Mengnan Liu1
1Department of General Surgery, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai, 200438, China.
Materials today. Bio
|March 19, 2025
概括
这项研究引入了一种新的纳米系统,该纳米系统针对肝细胞癌 (HCC) 瘤细胞代谢. 通过阻断关键的代谢通路,它提高了放射治疗 (RT) 的有效性,并克服了HCC的治疗耐药性.
科学领域:
- 在瘤学瘤学.
- 代谢工程是代谢工程.
- 纳米医学是一种纳米医学.
背景情况:
- 放射治疗 (RT) 是肝细胞癌 (HCC) 的主要治疗方法,但它会诱导存活的瘤细胞的代谢重编程,降低治疗的敏感性.
- 目前针对瘤的代谢疗法主要针对糖解,往往导致补偿性代谢变化,耐药性和复发.
研究的目的:
- 开发一种瘤特异性策略,以抵消RT诱导的HCC中的代谢重编程.
- 研究一种双重代谢阻塞方法,针对糖解和谷氨酸代谢途径.
主要方法:
- 一个新的纳米系统 (2-DG/BP MRs) 被设计为向瘤细胞表面营养物质的载体.
- 该纳米系统由X射线辐射触发,同时抑制HCC细胞中的糖解和谷氨酸代谢.
- 该战略重点是重新配置瘤细胞代谢以提高RT疗效.
主要成果:
- 该纳米系统有效地重新配置瘤细胞内的代谢途径,抵消RT诱导的代谢重编程.
- 双重代谢抑制破坏了癌细胞增殖所必需的能量供应.
- 这种方法证明了瘤细胞的特异性,避免了正常细胞的代谢障碍.
结论:
- 这种瘤特异性代谢干预通过双重代谢途径阻塞使HCC对RT敏感.
- 该策略提供了一种安全有效的方法,用于RT耐药HCC的组合疗法.
- 这种方法解决了当前代谢疗法的局限性,通过防止补偿代谢变化和增强治疗结果.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.7K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
368
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Carrier-Mediated Transport
225
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
225
